Skip to main content
SpringerLink
Log in

Production of chemoattractant byHelicobacter pylori

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Helicobacter pylori is present in the antral region of the stomach in a majority of patients with gastritis type B. The specific mechanism whereby the organism participates in the development of disease remains uncertain. Since the organism is not invasive, we postulate thatH. pylori produces a chemoattractant that recruits inflammatory cells to the antral region of the stomach.H. pylori was grown under microaerophilic conditions at 37°C for 72 hr inBrucella broth containing 1% fetal bovine serum. Culture supernates were harvested after removal of organisms by centrifugation and filtration. The putative chemoattractant in culture supernates as well as that which might be present endogenously in the growth medium (negative control) was assayed against human neutrophils (PMN) in modified Boyden blind-well chambers using 3.0-μm membranes. We found thatH. pylori supernates are chemotactic and showed up to 130% activity when compared to the positive chemoattractant control (zymosan-activated serum, a source of C5a). Minimal activity was observed with virgin growth medium. The chemoattractant activity is proportional to the number of colony forming units (CFU) ofH. pylori. Preliminary characterization of the activity shows that the chemoattractant is stable in a boiling water bath for 15 min, activity is lost within 1 hr in acid or alkali, and the chemotactic factor has an approximate molecular weight of 8500 daltons. The factor has no amino-sugar and is negative for the lipid, A portion of lipopolysaccharide. The chemotactic factor may be related to the recruitment of PMN into the lamina propria of the stomach in patients with gastritis, and it may afford an additional target for design of unique therapeutic interventions in chronic gastritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Blaser MJ, Brown WR: Campylobacters and gastroduodenal inflammation. Adv Intern Med 34:21–42, 1989

    Google Scholar 

  2. Blaser MJ: Hypothesis on the pathogenesis and natural history ofHelicobactor pylori-induced inflammation. Gastroenterology 102:720–727, 1992

    Google Scholar 

  3. Goodwin CS, Amstrong JA, Marshall BJ:Campylobacter pyloridis, gastritis and peptic ulceration. J Clin Pathol 39:353–365, 1980

    Google Scholar 

  4. Graham DY:Campylobacter pylori and peptic ulcer disease. Gastroenterology 96:615–662, 1989

    Google Scholar 

  5. Bizzuzero G: Uber die schlauchfoermigen drusen des magendarmkanals und die beziehungen ihres epithels zu dem uberfachenepithel der schleimhaut. Arch Mikrosk Anat 42:82–152, 1893

    Google Scholar 

  6. Warren JR, Marshall B: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 2:1273–1275, 1983

    Google Scholar 

  7. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311–1313, 1984

    Google Scholar 

  8. Marshall BJ: History of the discovery ofCampylobacter pylori.In Campylobacter pylori: In gastritis and peptic ulcer disease. MJ Blaser (ed). New York, Igaku Shoin Medical Publisher, 1987, pp 7–23

    Google Scholar 

  9. Jones DM, Lessells AM, Eldridge J: Campylobacter-like organisms and serologic studies. J Clin Pathol 37:1002–1006, 1984

    Google Scholar 

  10. Romaniuk PZ, Zoltowska B, Trust TJ, Lane DJ, Olsen GJ, Pace NR, Stahl DA:Campylobacter pylori, the spiral organism associated with human gastritis is not a trueCampylobacter species. J Bacteriol 169:2137–2141, 1987

    Google Scholar 

  11. Goodwin CS, McCulloch RK, Armstrong JA, Wee SH: Unusual cellular fatty acids and distinctive ultrastructure in a new spiral bacterium (Campylobacter pyloridis) from the human gastric mucosa. J Med Microbiol 19:257–267, 1985

    Google Scholar 

  12. Langenberg ML, Tytgat GMJ, Schipper MEI, Rietra PJGM, Zanen HC: Campylobacter-like organisms in the stomach of patients and healthy individuals. Lancet 1:1348, 1984

    Google Scholar 

  13. Taylor DE, Hargreaves JA, LaiKing NG, Sherbaniuk RW, Jewell LD: Isolation and characterization ofCampylobacter pyloridis from gastric biopsies. Am J Clin Pathol 87:49–54, 1987

    Google Scholar 

  14. Goodwin CS, Armstrong JA, Chilvers T, Peters M, Collins MD, Sly L, McConnell W, Harper WES: Transfer ofCampylobacter pylori andCampylobacter mustelae to Helicobacter gen. nov. asHelicobacter pylori comb. nov. andHelicobacter mustelae comb. nov., respectively. Int J Syst Bacteriol 39:399–405, 1989

    Google Scholar 

  15. Steer HW: Surface morphology of the gastroduodenal mucosa in duodenal ulceration. Gut 25:1203–1210, 1984

    Google Scholar 

  16. Fukuda T, Kimura S, Arakawa T, Kobayashi K: Possible role of leukotrienes in gastritis associated withCampylobacter pylori. J Clin Gastroenterol 12:531–534, 1990

    Google Scholar 

  17. Satoh K, Kimura K, Yoshida Y, Kasano T, Kihira K, Taniguchi Y: A topographic relationship betweenHelicobacter pylori and gastritis: Quantitative assessment ofHelicobacter pylori in the gastric mucosa. Am J Gastroenterol 86:285–291, 1991

    Google Scholar 

  18. Chester JF, Ross JS, Malt RA, Weitzman SA: Acute colitis produced by chemotactic peptide in rats and mice. Am J Pathol 121:284–290, 1985

    Google Scholar 

  19. Marasco WA, Phan SH, Krutzsch H, Showell HJ, Feltner DE Nairn R, Becker EL, Ward PA: Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced byEscherichia coli. J Biol Chem 259:5430–5439, 1984

    Google Scholar 

  20. Nast CC, LeDuc LE: Chemotactic peptides, mechanisms, functions and possible role in inflammatory bowel disease. Dig Dis Sci 33:S50-S57, 1988

    Google Scholar 

  21. Sloan B, Abrams WR, Meranze DR, Kimbel P, Weinbaum G: Emphysema inducedin vitro andin vivo in dogs by a purified elastase from homologous leukocytes. Am Rev Respir Dis 124:295–301, 1981

    Google Scholar 

  22. Davidson EA: Analysis of sugars found in mucopolysaccharides..In Methods in Enzymology, Vol. VIII. Complex Carbohydrates. EF Neufeld and V Ginsburg (eds). Academic Press, New York, 1966, pp 58–59

    Google Scholar 

  23. Freer JH, Salton MRJ: The anatomy and chemistry of cell envelopes.In Microbial Toxins, Vol. IV. Bacterial Endotoxins. G Weinbaum, S Kadis, SJ Ajl (eds). Academic Press, New York, 1971, pp 112–116

    Google Scholar 

  24. Ashwell G: New colorimetric methods of sugar analysis.In Methods in Enzymology, Vol. VIII. Complex Carbohydrates. EF Neufeld and V Ginsburg (eds). Academic Press, New York, 1966, pp 89–92

    Google Scholar 

  25. Mai UEH, Perez-Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD: Soluble surface proteins fromHelicobacter pylori activate monocyte/macrophage by lipopolysaccharide independent mechanism. J Clin Invest 87:894–900, 1991

    Google Scholar 

  26. Craig PM, Karnes WE, Territo MC, Walsh JH:Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut 33:1020–1023, 1992

    Google Scholar 

  27. Nielsen H, Andersen LP: Chemotactic activity ofHelicobacter pylori sonicate for human polymorphonuclear leukocytes and monocytes. Gut 33:738–742, 1992

    Google Scholar 

  28. Czinn S, Carr H, Yong P: Demonstration of a soluble phosphodiesterase, phospholipase C (PLC) produced byHelicobacter pylori: A potential virulence factor. Am J Gastroenterol A57, 1990

  29. Langenberg W, Rauws AJ, Houthoff HJ, Oudbier JH, Van Bohemen CG, Tytgat GNJ, Rietra PJGM: Follow-up study of individuals with untreatedCampylobacter pylori associated gastritis and of non-infected persons with non-ulcer dyspepsia. J Infect Dis 157:1245–1249, 1988

    Google Scholar 

Download references

Author information

Author notes

  1. A. Reymunde MD

    Present address: Gastroenterology Department, Damas Hospital, Ponce, Puerto Rico

Authors and Affiliations

  1. Division of Gastroenterology, Department of Medicine, The Graduate Hospital, One Graduate Plaza, 19146, Philadelphia, Pennsylvania

    A. Reymunde MD,  J. Deren MD, I. Nachamkin MD, D. Oppenheim BS & G. Weinbaum PhD

  2. University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

    A. Reymunde MD,  J. Deren MD, I. Nachamkin MD, D. Oppenheim BS & G. Weinbaum PhD

Authors
  1. A. Reymunde MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Deren MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Nachamkin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Oppenheim BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Weinbaum PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reymunde, A., Deren, J., Nachamkin, I. et al. Production of chemoattractant byHelicobacter pylori . Digest Dis Sci 38, 1697–1701 (1993). https://doi.org/10.1007/BF01303180

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01303180

Key Words

Search

Navigation